Our analysis of NF-κB subunit activity in CLL demonstrates that, as well as the p65 subunit, which has previously been demonstrated to define outcome [16], other subunits, including RelB, can be highly expressed in CLL. This evidence concerns the gene RELA and B-cell chronic lymphocytic leukemia.